Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, J. H.
Right arrow Articles by McKenna, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J. H.
Right arrow Articles by McKenna, W. G.
(Radiology. 1999;213:845-852.)
© RSNA, 1999


Radiation Oncology

Non-Small Cell Lung Cancer: Prognostic Factors in Patients Treated with Surgery and Postoperative Radiation Therapy1

Jason H. Lee, MD, Mitchell Machtay, MD, Larry R. Kaiser, MD, Joseph S. Friedberg, MD, Stephen M. Hahn, MD, Michael G. McKenna, MD and W. Gillies McKenna, MD, PhD

1 From the Department of Radiation Oncology (J.H.L., M.M., S.M.H., M.G.M., W.G.M.) and the Divisions of Thoracic Surgery (L.R.K., J.S.F.) and Hematology/Oncology (S.M.H.), University of Pennsylvania Medical Center, 3400 Spruce St, 2 Donner, Philadelphia, PA 19104. From the 1998 RSNA scientific assembly. Received November 30, 1998; revision requested January 14, 1999; revision received March 1; accepted July 1. Address reprint requests to M.M. (e-mail: machtay@xrt.upenn.edu).

PURPOSE: To determine survival outcomes, to identify adverse prognostic factors for relapse, and to compare American Joint Commission on Cancer (AJCC) staging systems in patients with non–small cell lung cancer (NSCLC) treated with surgery and postoperative radiation therapy.

MATERIALS AND METHODS: Between 1980 and 1995, 211 patients with NSCLC underwent surgery and postoperative radiation therapy. Surgery consisted of wedge resection (12.5%), lobectomy (67.8%), or pneumonectomy (19.7%). Pathologic stages (1992 AJCC) included I (n = 22), II (n = 70), IIIA (n = 104), and IIIB (n = 12). Indications for radiation therapy included compromised margins (n = 81) and/or positive mediastinal nodes (n = 55). Prognostic factors were identified by using univariate and multivariate models.

RESULTS: Overall 3-year survival for patients with stage I, II, and IIIA cancer was 58.9%, 44.1%, and 43.2%, respectively. Older age (P = .008), male sex (P = .021), large primary tumor (P = .004), and multiple positive mediastinal nodes (P = .046) were associated with worse rates of survival. Actuarial risk of local-regional relapse (36 patients) was 21.4% at 3 years. In a multivariate model, use of wedge resection (P = .001), positive margins (P = .010), and larger pathologic tumor (P = .059) were risk factors for local-regional recurrence. Actuarial rate of distant failure was 55.2% at 3 years.

CONCLUSION: Local-regional control can be achieved with surgery and radiation therapy in approximately 80% of patients; however, the rate of distant metastasis remains unacceptably high. Other variables, such as multiple positive nodes, may serve to identify patients at higher risk for relapse and poorer survival. Methods for improving treatment outcomes in these patients should be pursued.

Index terms: Lung neoplasms, 60.321 • Lung neoplasms, surgery, 60.321, 60.45 • Lung neoplasms, therapeutic radiology, 60.321, 60.1299




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
A. Linkous, L. Geng, A. Lyshchik, D. E. Hallahan, and E. M. Yazlovitskaya
Cytosolic Phospholipase A2: Targeting Cancer through the Tumor Vasculature
Clin. Cancer Res., March 1, 2009; 15(5): 1635 - 1644.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. D. Brundage, D. Davies, and W. J. Mackillop
Prognostic Factors in Non-small Cell Lung Cancer* : A Decade of Progress
Chest, September 1, 2002; 122(3): 1037 - 1057.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Machtay, J. H. Lee, J. B. Shrager, L. R. Kaiser, and E. Glatstein
Risk of Death From Intercurrent Disease Is Not Excessively Increased by Modern Postoperative Radiotherapy for High-Risk Resected Non-Small-Cell Lung Carcinoma
J. Clin. Oncol., October 1, 2001; 19(19): 3912 - 3917.
[Abstract] [Full Text]